Targeting CD22 as a strategy for treating systemic autoimmune diseases

por Dörner, Thomas, Goldenberg, David M
Publicado 2007

Enhancing the antitumor potency of T cells redirected by bispecific antibodies

por Chang, Chien-Hsing, Goldenberg, David M.
Publicado 2017

New Antibody Conjugates in Cancer Therapy

por Govindan, Serengulam V., Goldenberg, David M.
Publicado 2010

The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target

por Goldenberg, David M., Stein, Rhona, Sharkey, Robert M.
Publicado 2018

Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types

por Burton, Jack D., Goldenberg, David M., Blumenthal, Rosalyn D.
Publicado 2008

Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus

por Rossi, Edmund A., Chang, Chien-Hsing, Goldenberg, David M.
Publicado 2014

Monoclonal antibodies targeting CD20

por Chang, Chien-Hsing, Rossi, Edmund A., Goldenberg, David M.
Publicado 2013

Radiofluorination using aluminum-fluoride (Al(18)F)

por McBride, William J, Sharkey, Robert M, Goldenberg, David M
Publicado 2013

Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin

por Gold, David V, Newsome, Guy, Liu, Donglin, Goldenberg, David M
Publicado 2013

Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells

por Chang, Chien-Hsing, Wang, Yang, Gupta, Pankaj, Goldenberg, David M
Publicado 2014

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers

por Blumenthal, Rosalyn D, Leon, Evelyn, Hansen, Hans J, Goldenberg, David M
Publicado 2007

Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: A promising biomarker and therapeutic target for pancreatic cancer

por Liu, Donglin, Chang, Chien-Hsing, Gold, David V., Goldenberg, David M.
Publicado 2015

Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitro

por Cardillo, Thomas M, Trisal, Preeti, Arrojo, Roberto, Goldenberg, David M, Chang, Chien-Hsing
Publicado 2013

In-Vivo Fusion of Human Cancer and Hamster Stromal Cells Permanently Transduces and Transcribes Human DNA

por Goldenberg, David M., Rooney, Robert J., Loo, Meiyu, Liu, Donglin, Chang, Chien-Hsing
Publicado 2014

Interferon-λ1 Linked to a Stabilized Dimer of Fab Potently Enhances both Antitumor and Antiviral Activities in Targeted Cells

por Liu, Donglin, Chang, Chien-Hsing, Rossi, Edmund A., Cardillo, Thomas M., Goldenberg, David M.
Publicado 2013

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus

por Dörner, Thomas, Kaufmann, Joerg, Wegener, William A, Teoh, Nick, Goldenberg, David M, Burmester, Gerd R
Publicado 2006

Correction: Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus

por Dörner, Thomas, Kaufmann, Joerg, Wegener, William A, Teoh, Nick, Goldenberg, David M, Burmester, Gerd R
Publicado 2008

Horizontal Transmission of Malignancy: In-Vivo Fusion of Human Lymphomas with Hamster Stroma Produces Tumors Retaining Human Genes and Lymphoid Pathology

por Goldenberg, David M., Gold, David V., Loo, Meiyu, Liu, Donglin, Chang, Chien-Hsing, Jaffe, Elaine S.
Publicado 2013

Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*

por Goldenberg, David M., Cardillo, Thomas M., Govindan, Serengulam V., Rossi, Edmund A., Sharkey, Robert M.
Publicado 2015

Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models

por Elekonawo, Fortuné M. K., Bos, Desirée L., Goldenberg, David M., Boerman, Otto C., Rijpkema, Mark
Publicado 2019